jim hinrichs

board member and audit committee chair

About

Operationally-focused finance executive with nearly thirty years of experience in healthcare - twenty years in pharma/biotech at two Fortune 100 companies and a pre-revenue biotechnology company, as well as ten years in medical devices/diagnostics as the CFO at two multi-billion dollar companies. Managed more than twenty M&A/capital markets transactions including a $4 billion spin-off, the sale of two large ($8 billion and $12 billion) companies, $2+ billion in debt offerings and a $100 million IPO. Led global investor relations activities for five publicly traded companies. Specific skills in management of Wall Street/Investor relationships, large M&A, driving global operating improvements and merger integration in large complex organizations, crisis management in the areas of compliance, FCPA and SEC related matters, and building and leading finance organizations through significant change.

Country

united states

City

columbus

Industry

medical devices

Skill

construction safety

Experience

member board of directors and audit committee chair

orthofix

2014-4 - Present · 12 yrs 6 mos

senior director, global financial transactions

merck

1999-5 - 2004-2 · 4 yrs 10 mos

Led the Company’s global efforts to streamline and automate all financial transaction processes and systems

chief financial officer

sangstat medical

1997-12 - 1999-4 · 1 yr 5 mos

CFO of this publicly traded biotechnology company focusing on the discovery, development and marketing of products for organ transplantation and autoimmune diseases. In 2002, the Company was sold to Genzyme. During my time as CFO, the company grew from $5 million to $60 million in revenue.

multiple positions

merck

1990-6 - 1997-12 · 7 yrs 7 mos

Multiple positions in Finance and Marketing including, Director of Investor Relations, Customer Manager, Manager Pension Investments and Treasury Analyst

board member and audit committee chair

vice president and chief financial officer

sangstat

1997-1 - 1999-1 · 2 yrs 1 mo

director investor relations

merck

1994-1 - 1997-1 · 3 yrs 1 mo

pension manager

merck

1992-1 - 1994-1 · 2 yrs 1 mo

analyst

merck

1990-1 - 1992-1 · 2 yrs 1 mo

chief financial officer

cibus

2018-5 - 2019-7 · 1 yr 3 mos

chief financial officer

carefusion

2010-12 - 2015-3 · 4 yrs 4 mos

Global responsibility for Finance, Strategy and Development As part of the leadership team, drove operating margins from approximately 13% to 21% over four years via operating improvements and portfolio management. Over 4 years, more than tripled the market capitalization of the company from approximately $4 billion to over $12 billion when it was acquired by Becton Dickinson in March 2015.

senior vice president global customer support

carefusion

2009-12 - 2010-12 · 1 yr 1 mo

Global responsibility for CareFusion's customer support, which included a $200+million revenue line, $180M of expenses, and a 2,000 person (primarily field-based) team.

senior vice president controller

carefusion

2009-1 - 2009-12 · 1 yr

Controller and lead financial person for the spinout of CareFusion from Cardinal Health

member board of directors

integer holdings corporation

2018-2 - Present · 8 yrs 8 mos

executive vice president and cfo, healthcare supply chain services

cardinal health

2008-1 - 2009-1 · 1 yr 1 mo

Led all financial matters relating to the $87 billion operations of this segment. Responsibilities included accounting, reporting, FP&A, strategic pricing and customer profitability.

executive vice president and chief financial officer

alere

2015-4 - 2017-10 · 2 yrs 7 mos

By developing new capabilities in near-patient diagnosis, monitoring and health information technology, we enable individuals to take charge of improving their health and quality of life at home. Our global leading products, services, and new product development efforts bring the power of diagnostics directly to patients.Our socially-conscious business approach focuses on creating breakthrough, cost-effective diagnostic solutions that address the most intractable diseases for all populations in all corners of the world including infectious disease, toxicology, cardiology, and diabetes.Alere is committed to delivering high-quality products and services that patients and providers can rely on for consistently accurate and actionable information. We deploy unique innovative technologies that not only transform diagnostic products, but also expand into new platforms and solutions with proven health and economic outcomes.